Comprehensive functional assessment of MLH1 variants of unknown significance

被引:30
|
作者
Borras, Ester [1 ]
Pineda, Marta [1 ]
Brieger, Angela [2 ]
Hinrichsen, Inge [2 ]
Gomez, Carolina [1 ]
Navarro, Matilde [1 ]
Balmana, Judit [3 ]
Ramon y Cajal, Teresa [4 ]
Torres, Asuncion [5 ]
Brunet, Joan [6 ]
Blanco, Ignacio [1 ]
Plotz, Guido [2 ]
Lazaro, Conxi [1 ]
Capella, Gabriel [1 ]
机构
[1] ICO IDIBELL, Hereditary Canc Program, Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[2] Johann Wolfgang Goethe Univ Clin, Med Clin 1, Frankfurt, Germany
[3] Hosp Univ Vall dHebron, Med Oncol Serv, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Med Oncol Serv, Barcelona, Spain
[5] Hosp Univ St Joan, Unitat Consell Genet, Reus, Spain
[6] ICO IdIBGI, Hereditary Canc Program, Catalan Inst Oncol, Girona, Spain
关键词
Lynch syndrome; MLH1; variants of unknown significance; functional characterization; DNA MISMATCH REPAIR; MSH2 MISSENSE MUTATIONS; CELL-FREE ASSAY; LYNCH-SYNDROME; ADENOMATOUS POLYPOSIS; MESSENGER-RNA; SILENT MUTATIONS; GENES; MUTL; POLYMORPHISMS;
D O I
10.1002/humu.22142
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome is associated with germline mutations in DNA mismatch repair (MMR) genes. Up to 30% of DNA changes found are variants of unknown significance (VUS). Our aim was to assess the pathogenicity of eight MLH1 VUS identified in patients suspected of Lynch syndrome. All of them are novel or not previously characterized. For their classification, we followed a strategy that integrates family history, tumor pathology, and control frequency data with a variety of in silico and in vitro analyses at RNA and protein level, such as MMR assay, MLH1 and PMS2 expression, and subcellular localization. Five MLH1 VUS were classified as pathogenic: c.[248G>T(;)306G>C], c.[780C>G;788A>C], and c.791-7T>A affected mRNA processing, whereas c.218T>C (p.L73P) and c.244G>A (p.T82A) impaired MMR activity. Two other VUS were considered likely neutral: the silent c.702G>A variant did not affect mRNA processing or stability, and c.974G>A (p.R325Q) did not influence MMR function. In contrast, variant c.25C>T (p.R9W) could not be classified, as it associated with intermediate levels of MMR activity. Comprehensive functional assessment of MLH1 variants was useful in their classification and became relevant in the diagnosis and genetic counseling of carrier families. Hum Mutat 33:15761588, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1576 / 1588
页数:13
相关论文
共 50 条
  • [21] Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae
    Hideki Shimodaira
    Nicole Filosi
    Hiroyuki Shibata
    Takao Suzuki
    Paolo Radice
    Ryunosuke Kanamaru
    Stephen H. Friend
    Richard D. Kolodner
    Chikashi Ishioka
    Nature Genetics, 1998, 19 : 384 - 389
  • [22] From variant of unknown significance to likely pathogenic: Characterization and pathogenicity determination of a large genomic deletion in the MLH1 gene
    Bouras, Ahmed
    Legrand, Clementine
    Kourda, Jihen
    Ruano, Eric
    Grand-Masson, Chloe
    Lefol, Cedrick
    Wang, Qing
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (09):
  • [23] Functional analysis of human MLH1 mutations in Saccharomyces cevevisiae
    Shimodaira, H
    Filosi, N
    Shibata, H
    Suzuki, T
    Radice, P
    Kanamaru, R
    Friend, SH
    Kolodner, RD
    Ishioka, C
    NATURE GENETICS, 1998, 19 (04) : 384 - 389
  • [24] Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice
    Edelmann, W
    Yang, F
    Kuraguchi, M
    Heyer, J
    Lia, M
    Kneitz, B
    Fan, KH
    Brown, AMC
    Lipkin, M
    Kucherlapati, R
    CANCER RESEARCH, 1999, 59 (06) : 1301 - 1307
  • [25] IMMUNOEXPRESSION AND CLINICAL SIGNIFICANCE OF THE PTEN AND MLH1 PROTEINS IN ENDOMETRIAL CARCINOMAS
    Bakiewicz, Anna
    Michalak, Jacek
    Sporny, Stanislaw
    POLISH JOURNAL OF PATHOLOGY, 2010, 61 (04) : 185 - 191
  • [26] Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
    Bosch, Dustin E.
    Yeh, Matthew M.
    Salipante, Stephen J.
    Jacobson, Angela
    Cohen, Stacey A.
    Konnick, Eric Q.
    Paulson, Vera A.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [27] Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants
    Tricarico, Rossella
    Kasela, Mariann
    Mareni, Cristina
    Thompson, Bryony A.
    Drouet, Aurelie
    Staderini, Lucia
    Gorelli, Greta
    Crucianelli, Francesca
    Ingrosso, Valentina
    Kantelinen, Jukka
    Papi, Laura
    De Angioletti, Maria
    Berardi, Margherita
    Gaildrat, Pascaline
    Soukarieh, Omar
    Turchetti, Daniela
    Martins, Alexandra
    Spurdle, Amanda B.
    Nystrom, Minna
    Genuardi, Maurizio
    HUMAN MUTATION, 2017, 38 (01) : 64 - 77
  • [28] Predicting the Functional Impact of KCNQ1 Variants of Unknown Significance
    Li, Bian
    Mendenhall, Jeffrey L.
    Kroncke, Brett M.
    Taylor, Keenan C.
    Huang, Hui
    Smith, Derek K.
    Vanoye, Carlos G.
    Blume, Jeffrey D.
    George, Alfred L.
    Sanders, Charles R.
    Meiler, Jens
    CIRCULATION-CARDIOVASCULAR GENETICS, 2017, 10 (05)
  • [29] Common variants on MLH1 gene and their associations with prostate cancer in European Americans
    Xi, Huifeng
    Pal, Prodipto
    Guha, Saurav
    Sun, Guangyun
    Meeks, Joshua J.
    Helfand, Brian T.
    Suarez, Brian K.
    Catalona, William J.
    Deka, Rarjan
    JOURNAL OF UROLOGY, 2008, 179 (04): : 227 - 227
  • [30] Utility of MLH1 Hypermethylation Analysis in MLH1 Deficient Endometrial Carcinomas: Is It Best Practice?
    Plotkin, Anna
    Olkhov-Mitsel, Ekaterina
    Nofech-Mozes, Sharon
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1739 - S1740